Cardio-ocular syndrome: Retinal microvascular changes in acutely decompensated heart failure.
Acute heart failure
Congestion
Optical coherence tomography angiography
Retinal microvascular changes
Journal
European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595
Informations de publication
Date de publication:
24 Sep 2024
24 Sep 2024
Historique:
revised:
19
08
2024
received:
19
06
2024
accepted:
04
09
2024
medline:
25
9
2024
pubmed:
25
9
2024
entrez:
24
9
2024
Statut:
aheadofprint
Résumé
To investigate the changes in retinal microvasculature by contemporary imaging techniques during episodes of acute decompensated heart failure (ADHF) and following recompensation compared to age-matched controls without known cardiac or retinal disease. Adult patients hospitalized with a primary diagnosis of ADHF, regardless of left ventricular ejection fraction (LVEF) and treated with a minimum dose of 40 mg of intravenous furosemide or equivalent were included. Transthoracic echocardiography was conducted in all patients. Eye examinations were performed out within the initial 24 h after admission and after recompensation before discharge. All eyes underwent a general examination, including a best corrected visual acuity test, dilated fundoscopy, spectral-domain optical coherence tomography (OCT) as well as OCT angiography (OCT-A). In addition, 40 participants without documented cardiac or retinal diseases served as controls. Forty patients with ADHF (mean age 78.9 ± 8.8 years; 32% female) with a mean LVEF of 43 ± 12.8% were included. All patients were treated with intravenous diuretics for a median of 4.3 ± 2.8 days. There was a significant reduction in N-terminal pro-B-type natriuretic peptide from baseline up to discharge (10 396 [interquartile range 6410] vs. 6380 [interquartile range 3933] pg/ml, p ≤ 0.001) and inferior vena cava diameters (2.13 ± 0.4 vs. 1.63 ± 0.3 cm, p = 0.003). Compared to the control group, patients with ADHF showed on admission impaired visual acuity (0.15 ± 0.1 vs. 0.35 ± 0.1 logMAR, p < 0.001), reduced macular vessel density (18.0 ± 1.9 vs. 14.3 ± 3.6 mm/mm This analysis revealed a remarkable reversible change in retinal microvasculature after ADHF. This could provide a valuable evidence for use of OCT-A in the assessment of overall microperfusion and haemodynamic status in patients with acute heart failure.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics‐2018 update: A report from the American Heart Association. Circulation 2018;137:e67–e492. https://doi.org/10.1161/CIR.0000000000000558
Boorsma EM, Ter Maaten JM, Damman K, Dinh W, Gustafsson F, Goldsmith S, et al. Congestion in heart failure: A contemporary look at physiology, diagnosis and treatment. Nat Rev Cardiol 2020;17:641–655. https://doi.org/10.1038/s41569‐020‐0379‐7
Martens P, Nijst P, Mullens W. Current approach to decongestive therapy in acute heart failure. Curr Heart Fail Rep 2015;12:367–378. https://doi.org/10.1007/s11897‐015‐0273‐5
Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner‐La Rocca HP, et al. Organ dysfunction, injury and failure in acute heart failure: From pathophysiology to diagnosis and management. A review on behalf of The Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 2017;19:821–836. https://doi.org/10.1002/ejhf.872
Böhm EW, Grauhan NF, Pfeiffer N, Gericke A. Measurement of retrobulbar blood flow and vascular reactivity – relevance for ocular and cardiovascular diseases. Diagnostics (Basel) 2023;13:3514. https://doi.org/10.3390/diagnostics13233514
Zampiccoli E, Barthelmes J, Kreysing L, Nägele MP, Nebunu D, Haider T, et al. Eyes on amyloidosis: Microvascular retinal dysfunction in cardiac amyloidosis. ESC Heart Fail 2022;9:1186–1194. https://doi.org/10.1002/ehf2.13792
Wong TY, Rosamond W, Chang PP, Couper DJ, Sharrett AR, Hubbard LD, et al. Retinopathy and risk of congestive heart failure. JAMA 2005;293:63–69. https://doi.org/10.1001/jama.293.1.63
Cheung N, Bluemke DA, Klein R, Sharrett AR, Islam FM, Cotch MF, et al. Retinal arteriolar narrowing and left ventricular remodeling: The Multi‐Ethnic Study of Atherosclerosis. J Am Coll Cardiol 2007;50:48–55. https://doi.org/10.1016/j.jacc.2007.03.029
Nägele MP, Barthelmes J, Ludovici V, Cantatore S, von Eckardstein A, Enseleit F, et al. Retinal microvascular dysfunction in heart failure. Eur Heart J 2017;39:47–56. https://doi.org/10.1093/eurheartj/ehx565
Chandra A, Seidelmann SB, Claggett BL, Klein BE, Klein R, Shah AM, et al. The association of retinal vessel calibres with heart failure and long‐term alterations in cardiac structure and function: The Atherosclerosis Risk in Communities (ARIC) study. Eur J Heart Fail 2019;21:1207–1215. https://doi.org/10.1002/ejhf.1564
Chaikijurajai T, Ehlers JP, Tang WHW. Retinal microvasculature: A potential window into heart failure prevention. JACC Heart Fail 2022;10:785–791. https://doi.org/10.1016/j.jchf.2022.07.004
Liew G, Wang JJ, Mitchell P, Wong TY. Retinal vascular imaging. Circ Cardiovasc Imaging 2008;1:156–161. https://doi.org/10.1161/CIRCIMAGING.108.784876
Lang RM, Badano LP, Mor‐Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1–39.e14. https://doi.org/10.1016/j.echo.2014.10.003
Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, Klein BE. Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 2003;27:143–149. https://doi.org/10.1076/ceyr.27.3.143.16049
Gündoğan M, Vural E, Bayram N, Altunel O, Gündoğan F, Göktaş S. Change in retinal vessel diameter and choroidal thickness in patients with severe COVID‐19. Photodiagnosis Photodyn Ther 2022;37:102674. https://doi.org/10.1016/j.pdpdt.2021.102674
Flammer J, Konieczka K, Bruno RM, Virdis A, Flammer AJ, Taddei S. The eye and the heart. Eur Heart J 2013;34:1270–1278. https://doi.org/10.1093/eurheartj/eht023
Ng JY, Zarook E, Nicholson L; Oculi‐Cordis group; Khanji MY, Chahal CAA. Eyes and the heart: What a clinician should know. Heart 2023;109:1670–1676. https://doi.org/10.1136/heartjnl‐2022‐322081
Leclaire MD, Eter N, Alnawaiseh M. Optical coherence tomography angiography and cardiovascular diseases. An overview of the current knowledge. Ophthalmologe 2021;118:1119–1127. https://doi.org/10.1007/s00347‐021‐01336‐1
Alnawaiseh M, Eckardt F, Mihailovic N, Frommeyer G, Diener R, Rosenberger F, et al. Ocular perfusion in patients with reduced left ventricular ejection fraction measured by optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol 2021;259:3605–3611. https://doi.org/10.1007/s00417‐021‐05253‐6
Rakusiewicz K, Kanigowska K, Hautz W, Ziółkowska L. The impact of chronic heart failure on retinal vessel density assessed by optical coherence tomography angiography in children with dilated cardiomyopathy. J Clin Med 2021;10:25. https://doi.org/10.3390/jcm10122659
Cotter G, Davison B. Acute heart failure is a remitting‐relapsing disorder and not a step towards advanced heart failure: Implications for decongestion therapy. Eur J Heart Fail 2023;25:933–935. https://doi.org/10.1002/ejhf.2916
Dauw J, Mullens W, Girerd N. The fastest way to the heart is through the veins: Towards a better understanding of congestion. Eur J Heart Fail 2022;24:463–465. https://doi.org/10.1002/ejhf.2442
Almeida‐Freitas DB, Meira‐Freitas D, Melo LA Jr, Paranhos A Jr, Iared W, Ajzen S. Color Doppler imaging of the ophthalmic artery in patients with chronic heart failure. Arq Bras Oftalmol 2011;74:326–329. https://doi.org/10.1590/s0004‐27492011000500003
Sterling MR, Jannat‐Khah D, Vitale S, Safford MM. Can your patients with heart failure see? The prevalence of visual impairment among adults with heart failure. J Gen Intern Med 2018;33:605–607. https://doi.org/10.1007/s11606‐018‐4366‐1
den Uil CA, Lagrand WK, Spronk PE, van der Ent M, Jewbali LS, Brugts JJ, et al. Low‐dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure. Eur J Heart Fail 2009;11:386–390. https://doi.org/10.1093/eurjhf/hfp021
Wijntjens GW, Fengler K, Fuernau G, Jung C, den Uil C, Akin S, et al. Prognostic implications of microcirculatory perfusion versus macrocirculatory perfusion in cardiogenic shock: A CULPRIT‐SHOCK substudy. Eur Heart J Acute Cardiovasc Care 2020;9:108–119. https://doi.org/10.1177/2048872619870035
De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J 2004;147:91–99. https://doi.org/10.1016/j.ahj.2003.07.006
den Uil CA, Lagrand WK, van der Ent M, Jewbali LS, Cheng JM, Spronk PE, et al. Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2010;31:3032–3039. https://doi.org/10.1093/eurheartj/ehq324
Altinkaynak H, Kara N, Sayın N, Güneş H, Avsar S, Yazıcı AT. Subfoveal choroidal thickness in patients with chronic heart failure analyzed by spectral‐domain optical coherence tomography. Curr Eye Res 2014;39:1123–1128. https://doi.org/10.3109/02713683.2014.898310
Rakusiewicz K, Kanigowska K, Hautz W, Ziółkowska L. Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy. Int Ophthalmol 2021;41:2167–2177. https://doi.org/10.1007/s10792‐021‐01774‐5